Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …

Background Pheochromocytomas and paragangliomas have up to a 20% rate of metastatic
disease that cannot be reliably predicted. This study prospectively assessed whether the …

Background Pheochromocytomas and paragangliomas (PPGLs) have a heterogeneous
prognosis, the basis of which remains unclear. We, therefore, assessed disease-specific …

Head and neck paragangliomas (HNPGLs) are tumors of parasympathetic origin that occur
at variable locations and are often secondary to germline mutations in succinate …

Context Long-term follow-up has been recommended for patients with pheochromocytoma
or paraganglioma (PPGL) due to potential for recurrent disease. However, the need to follow …

Adult and paediatric patients with pathogenic variants in the gene encoding succinate
dehydrogenase (SDH) subunit B (SDHB) often have locally aggressive, recurrent or metastatic …

Purpose To understand prognostic immune cell infiltration signatures in neuroendocrine
neoplasms (NENs), particularly pheochromocytoma and paraganglioma (PCPG), we analyzed …

Metastatic pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine
tumors associated with poor prognosis and limited therapeutic options. Recent advances in …

Pheochromocytomas and paragangliomas (PHEOs/PGLs) represent diagnostically challenging
and complex neuroendocrine tumors (NETs). Current biomarker tests for PHEOs/PGLs …

Please see the Editorial Comment by Erin E. Grady discussing this article. To listen to the
podcast associated with this article, please select one of the following: iTunes , Google Play , or …